PATENT CLAIM ANALYSIS

Application Number: 16302722
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["514", "323000"]

Abstract:
The present disclosure describes compositions and methods for treating at least one negative symptom in a human subject who does not have a clinical diagnosis of schizophrenia. The compositions and methods employ a therapeutically effective amount of a compound of formula (I), or a pharmaceutically acceptable salt, hydrate, solvate or polymorph thereof.

Claim (Index 18):
The method of  claim 17 , wherein the mental disorder or neurological condition is FTD, Alzheimer's disease, MDD, BPD or Parkinson's disease.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 98.0
- Lexical Diversity: 1.31111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15211638', '15853151', '15484960', '13213960', '14635905']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7121568515798253
- 35 USC 102 Novelty (BERT): 0.4746432204014835
- Combined Prediction Score: 0.6884054884619912
- Mean Citation Score: 159.67431399999995
- Max Citation Score: 170.6875
- Similarity Product: 130.12242918461558

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test